Cargando…
Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma
Metastasis and recurrence contribute to poor prognosis of hepatocellular carcinoma (HCC). Recently, we reported that interferon-α (IFN-α) can suppress metastasis of HCC; however, the underlying mechanism has not been fully described. In this study, we demonstrated that expression of dihydropyrimidin...
Autores principales: | Zhu, Wei-Ping, Liu, Ze-Yang, Zhao, Yi-Ming, He, Xi-Gan, Pan, Qi, Zhang, Ning, Zhou, Jia-Min, Wang, Long-Rong, Wang, Miao, Zhan, Di-Hua, Ma, De-Ning, Wang, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833634/ https://www.ncbi.nlm.nih.gov/pubmed/29358721 http://dx.doi.org/10.1038/s41419-017-0098-0 |
Ejemplares similares
-
Dihydropyrimidine Dehydrogenase Deficiency: To Screen or Not to Screen?
por: Vogel, Wendy H., et al.
Publicado: (2020) -
A ferredoxin-dependent dihydropyrimidine dehydrogenase in Clostridium chromiireducens
por: Wang, Feifei, et al.
Publicado: (2020) -
Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity
por: Milano, G, et al.
Publicado: (1999) -
Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours.
por: McLeod, H. L., et al.
Publicado: (1998) -
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer.
por: Ridge, S. A., et al.
Publicado: (1998)